PCV48 COST EFFECTIVENESS OF RIVAROXABAN IN CORONARY ARTERY DISEASE AND/OR PERIPHERAL ARTERY DISEASE FOR 5 DIFFEREN PATIENT SUB-GROUPS IN TURKEY
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.773
https://www.valueinhealthjournal.com/article/S1098-3015(19)33151-1/fulltext
Section Title :
Section Order :
10674
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33151-1&doi=10.1016/j.jval.2019.09.773